tradingkey.logo
tradingkey.logo
Search

AnaptysBio Inc

ANAB
Add to Watchlist
48.240USD
-0.960-1.95%
Market hours 10/06, 09:50(ET)
1.43BMarket Cap
LossP/E TTM

ANAB Financials

See AnaptysBio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.43B
Dividend TTM
0.00
P/E TTM
-47.30
EPS TTM
-1.02
Revenue
53.04M
Net Profit
-145.23M
ROE
-114.55%
ROA
-7.13%

AnaptysBio Inc Earnings Date

Latest Release
Sep 21, 2026
EPS / Forecast
6.16/0.94
Revenue / Forecast
27.49M/58.61M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q4
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
244.96%6.16
-43.62%-1.84
35.65%-0.46
147.76%0.54
21.39%-1.34
21.71%-1.28
54.97%-0.72
19.10%-1.14
-13.99%-1.71
-3.55%-1.64
-71.02%-1.59
---1.41
---1.50
---1.58
---0.93
---3.64
----
----
----
----
Revenue
-74.61%27.49M
-7.98%25.56M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
32.27%9.01M
156.61%3.32M
184.54%3.46M
41.65%1.37M
573.39%6.81M
-93.81%1.29M
-95.95%1.22M
-91.38%970.00K
-98.31%1.01M
--20.89M
Net Profit
270.62%183.88M
-34.47%-52.88M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
-59.81%-42.21M
-11.36%-37.31M
-22.40%-39.84M
-22.07%-44.26M
18.82%-26.41M
-402.58%-33.50M
-7488.34%-32.55M
-99.61%-36.26M
-196.71%-32.54M
71.95%-6.67M
Net Margin
1719.58%833.97%
-46.12%-206.93%
88.84%-5.64%
118.09%19.80%
59.20%-173.52%
76.86%-141.62%
89.22%-50.53%
90.27%-109.44%
63.07%-425.30%
81.00%-612.01%
-20.82%-468.75%
---1124.41%
---1151.59%
---3220.89%
---387.97%
---2940.82%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
6.63%80.92%
--80.00%
--75.89%
--93.98%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-74.61%27.49M
-7.98%25.56M
151.08%108.25M
154.26%76.32M
102.93%22.26M
286.84%27.77M
378.77%43.11M
804.67%30.02M
217.08%10.97M
422.49%7.18M
32.27%9.01M
156.61%3.32M
184.54%3.46M
41.65%1.37M
573.39%6.81M
-93.81%1.29M
-95.95%1.22M
-91.38%970.00K
-98.31%1.01M
--20.89M
Operating profit
0.09%66.96M
-25.77%-34.64M
791.84%66.90M
252.50%34.70M
35.10%-26.17M
34.74%-27.54M
72.21%-9.67M
39.69%-22.76M
-0.44%-40.32M
4.95%-42.20M
-33.97%-34.80M
-27.33%-37.73M
-44.40%-40.14M
-39.85%-44.40M
16.64%-25.97M
-338.16%-29.63M
-5115.57%-27.80M
-72.92%-31.75M
-193.44%-31.16M
72.21%-6.76M
Net Profit
270.62%183.88M
-34.47%-52.88M
327.75%49.61M
146.00%15.11M
17.21%-38.63M
10.49%-39.33M
48.39%-21.78M
11.95%-32.85M
-17.10%-46.66M
0.72%-43.94M
-59.81%-42.21M
-11.36%-37.31M
-22.40%-39.84M
-22.07%-44.26M
18.82%-26.41M
-402.58%-33.50M
-7488.34%-32.55M
-99.61%-36.26M
-196.71%-32.54M
71.95%-6.67M
Current assets
-43.35%198.43M
-12.94%316.11M
-18.90%350.25M
-26.31%330.65M
-20.54%291.91M
-2.50%363.11M
6.16%431.88M
4.83%448.68M
-16.23%367.35M
-14.81%372.42M
-9.03%406.83M
-4.98%428.00M
-3.15%438.54M
-14.69%437.15M
-19.26%447.20M
16.50%450.44M
13.75%452.81M
32.36%512.41M
39.67%553.88M
11.81%386.64M
Total current liabilities
-8.47%35.35M
-5.30%41.70M
-14.98%38.63M
-13.16%38.10M
-12.11%35.53M
36.35%44.04M
21.33%45.43M
12.00%43.88M
-2.91%40.42M
-9.77%32.30M
43.71%37.44M
86.00%39.18M
109.51%41.63M
80.96%35.80M
61.84%26.05M
0.83%21.06M
-3.61%19.87M
36.66%19.78M
-18.78%16.10M
-14.65%20.89M
Total assets
-13.01%316.98M
-21.89%329.68M
-24.69%364.39M
-28.44%353.10M
-21.56%335.25M
4.00%422.05M
6.95%483.83M
1.25%493.42M
-17.35%427.38M
-26.45%405.83M
-25.88%452.39M
-21.21%487.33M
-14.37%517.10M
-11.74%551.79M
-5.08%610.38M
45.76%618.50M
41.56%603.85M
57.70%625.17M
54.38%643.07M
10.29%424.33M
Total liabilities
-6.35%306.40M
-18.32%316.94M
-20.77%327.19M
-6.49%382.51M
-8.99%379.98M
8.37%388.03M
13.36%412.97M
11.48%409.05M
13.25%417.50M
-0.73%358.06M
4.60%364.29M
7.64%366.94M
23.07%368.65M
22.51%360.70M
21.50%348.28M
737.00%340.88M
633.49%299.54M
1934.02%294.42M
1346.15%286.64M
66.19%40.73M
Total equity
-71.55%10.59M
-62.53%12.75M
-47.49%37.21M
-134.87%-29.42M
-552.81%-44.73M
-28.79%34.02M
-19.56%70.87M
-29.92%84.37M
-93.35%9.88M
-75.00%47.78M
-66.39%88.10M
-56.64%120.38M
-51.22%148.45M
-42.22%191.09M
-26.46%262.10M
-27.63%277.62M
-21.11%304.31M
-13.40%330.75M
-10.16%356.43M
6.49%383.61M
Net operating income
-74.98%24.52M
-142.23%-25.92M
246.98%98.00M
-171.12%-27.36M
-88.74%-40.24M
71.28%-10.70M
-94.10%-66.67M
72.34%-10.09M
16.08%-21.32M
-51.63%-37.25M
-221.47%-34.35M
-105.52%-36.47M
-5.23%-25.41M
-16.91%-24.57M
57.77%-10.69M
-153.31%-17.75M
-351.77%-24.15M
9.44%-21.01M
-167.33%-25.30M
58.82%-7.01M
Net investment
-89.71%7.56M
135.62%34.98M
350.03%73.50M
76.19%103.28M
1590.70%36.40M
-78.36%14.85M
-159.77%-29.40M
91.35%58.62M
88.06%-2.44M
-19.65%68.62M
128.77%49.18M
194.45%30.64M
71.19%-20.45M
127.29%85.40M
132.23%21.50M
-399.23%-32.43M
-287.02%-71.00M
-651.59%-312.91M
-1953.64%-66.69M
129.06%10.84M
Net financing
110.28%4.43M
104.23%1.21M
-256.47%-43.13M
-114.59%-10.39M
-220.55%-50.50M
-109.71%-28.59M
634.35%27.57M
2418.68%71.23M
410.48%41.89M
63.72%-13.63M
-364.70%-5.16M
-108.30%-3.07M
-3223.15%-13.49M
-915.23%-37.57M
-99.22%1.95M
15263.90%37.03M
-22.02%432.00K
2659.88%4.61M
199373.02%251.34M
-8.37%241.00K

FAQs

What is the total revenue of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its total revenue reached 53.04M, with a year-on-year change of 234.60M.

What are the current assets of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its current assets were 198.43M, with a year-on-year change of -43.35.

What are the total assets of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its total assets of AnaptysBio Inc were 316.98M, with a year-on-year change of -13.01.

What are the total liabilities of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its total liabilities of AnaptysBio Inc were 306.40M, with a year-on-year change of -6.35.

What is the total equity of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its total equity of AnaptysBio Inc was 10.59M, with a year-on-year change of -71.55.

What is the net operating income of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its net operating income of AnaptysBio Inc was 40.52M, with a year-on-year change of -15.40.

What is the net investment of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its net investment of AnaptysBio Inc was 42.55M, with a year-on-year change of -81.34.

What is the net financing of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its net financing of AnaptysBio Inc was 5.64M, with a year-on-year change of 104.26.

What is the Earnings Per Share (EPS) of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its Earnings Per Share (EPS) was 4.52, with a year-on-year change of 1082.44.

What is the net income of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its net income was 131.00M, with a year-on-year change of 1089.99.

What is the net margin of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its net profit margin was 332.47, with a year-on-year change of 5994.77.

What is the debt-to-asset ratio of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its debt-to-asset ratio was 80.92, with a year-on-year change of 6.63.

What is the operating profit of AnaptysBio Inc?

According to AnaptysBio Inc's FY2026 earnings report, its operating profit was 40.52M, with a year-on-year change of -15.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.